Videos de Experimentos Relacionados
¿Antitrombóticos para el deterioro ventricular izquierdo?
1Yale Clinical Trials Office, Yale University School of Medicine, New Haven, CT 66510, USA.
Lancet (London, England)
|July 8, 1998
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Acute statin treatment in reducing risk after acute coronary syndrome: the MIRACL (Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering) Trial.
Current opinion in cardiology·2001
Same author
In vitro evaluation of c7E3-Fab (ReoPro) eluting polymer-coated coronary stents.
Cardiovascular research·2000
Same author
Labelling of platelets with indium-111 oxine and technetium-99m hexamethylpropylene amine oxime: suggested methods. International Society of Radiolabelled Blood Elements (ISORBE).
European journal of nuclear medicine·2000
Same author
Minimally invasive coronary artery bypass grafting: initial Connecticut experience.
Connecticut medicine·1997
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026